Merry Christmas and a happy New Year!
…have committed to remain open for business 2024. Looking forward to a new year of continued collaboration, groundbreaking research, and shared successes. 🎄 Happy Holidays and a Happy New Year!…
…have committed to remain open for business 2024. Looking forward to a new year of continued collaboration, groundbreaking research, and shared successes. 🎄 Happy Holidays and a Happy New Year!…
…for users. Personal dosimetry for other non-staff members (contractors, consultants etc.) A personal dosimeter is not required if you spend 3 months or less at MAX IV (Fotongatan) over the…
…users (50%) through the MAX IV user program. ForMAX MicroMAX beamline chevron_right The MicroMAX project is funded by Novo Nordisk Fonden (https://novonordiskfonden.dk/). The application was prepared by MAX IV Laboratory…
…existing machines with new capabilities, related to the user research at beamlines. Please, feel free to answer this short questionnaire as it will allow us to gauge the user interest…
FASM and MAX IV warmly invite MAX IV User communities, students, researchers, newly interested persons and collective to the 34th MAX IV User Meeting: “Collaboration in Focus”, 3-5 October 2022, at Scandic Star Hotel,…
Want to become a MAX IV user? Apply for beamtime! MAX IV is happy to welcome researchers from all over the world to come to Lund and perform experiments using…
…by emission from another atom. Publication Johan Söderström et al. Parity violation in resonant inelastic soft x-ray scattering at entangled core holes open_in_new Sci. Adv. 10, eadk3114(2024) DOI: 10.1126/sciadv.adk3114 open_in_new…
…controlled by tailor-made software. The GPES has been designed to accommodate a variety of sample preparation systems, provided by the FinEstBeAMS consortium, LDM group at MAX IV or external users….
The 36th MAX IV User Meeting will occur on 13–15 January 2025 in Lund, Sweden. More information will follow. The programme from the previous User Meeting – the 35th edition…
…Therefore, you need to start at the protein level to fight cancer. Sprint Bioscience is working to develop new drug candidates by identifying small molecules (fragments) that can bind targeted…